Related Experiment Video
Updated: Aug 7, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
Published on: May 17, 2013
EXTL3/EXTR1 alterations in colorectal cancer cell lines
T Arai1, Y Akiyama, H Nagasaki
1First Department of Surgery, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo 113-8519, Japan.
Researchers identified the EXTL3 gene as a potential tumor suppressor in colorectal cancer (CRC). Mutations and lack of expression in some CRC cell lines suggest EXTL3 inactivation may aid cancer cell growth.
Area of Science:
- Oncology
- Genetics
Background:
- Metastasis-related tumor suppressor genes may reside on chromosome 8p21-22 in early colorectal carcinomas (CRC).
- Previous allelotype analysis indicated this chromosomal region's potential role in CRC metastasis.
Purpose of the Study:
- To identify potential metastasis-related tumor suppressor genes within the 8p21-22 chromosomal region.
- To investigate the role of the EXTL3 gene, a homolog of known tumor suppressors EXT1 and EXT2, in colorectal cancer.
Main Methods:
- Searched the UniGene database for candidate genes in the 8p21-22 region.
- Screened 12 colorectal cancer (CRC) cell lines for mutations in the EXTL3 gene using polymerase chain reaction (PCR)-single strand conformation polymorphism.
- Analyzed EXTL3 gene expression in CRC cell lines via reverse transcription-PCR.
Main Results:
- Identified EXTL3 as a candidate gene due to homology with EXT1 and EXT2.
- Detected EXTL3 mutations in three out of 12 CRC cell lines, all within exon 3, leading to amino acid substitutions.
- Observed a lack of EXTL3 expression in one CRC cell line.
Conclusions:
- The EXTL3 gene is a potential tumor suppressor candidate in colorectal cancer.
- Inactivation of the EXTL3 gene may provide a selective growth advantage for certain colorectal cancer cell lines.
- Further research is needed to definitively establish EXTL3 as a tumor suppressor gene in CRC.
More Related Videos
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016